Tatham M H, Jaffray E, Vaughan O A, Desterro J M, Botting C H, Naismith J H, Hay R T
Institute of Biomolecular Sciences, University of St. Andrews, North Haugh, St. Andrews KY16 5ST, United Kingdom.
J Biol Chem. 2001 Sep 21;276(38):35368-74. doi: 10.1074/jbc.M104214200. Epub 2001 Jul 12.
Conjugation of the small ubiquitin-like modifier SUMO-1/SMT3C/Sentrin-1 to proteins in vitro is dependent on a heterodimeric E1 (SAE1/SAE2) and an E2 (Ubc9). Although SUMO-2/SMT3A/Sentrin-3 and SUMO-3/SMT3B/Sentrin-2 share 50% sequence identity with SUMO-1, they are functionally distinct. Inspection of the SUMO-2 and SUMO-3 sequences indicates that they both contain the sequence psiKXE, which represents the consensus SUMO modification site. As a consequence SAE1/SAE2 and Ubc9 catalyze the formation of polymeric chains of SUMO-2 and SUMO-3 on protein substrates in vitro, and SUMO-2 chains are detected in vivo. The ability to form polymeric chains is not shared by SUMO-1, and although all SUMO species use the same conjugation machinery, modification by SUMO-1 and SUMO-2/-3 may have distinct functional consequences.
体外,小泛素样修饰物SUMO-1/SMT3C/Sentrin-1与蛋白质的缀合依赖于异源二聚体E1(SAE1/SAE2)和E2(Ubc9)。尽管SUMO-2/SMT3A/Sentrin-3和SUMO-3/SMT3B/Sentrin-2与SUMO-1有50%的序列同一性,但它们在功能上是不同的。对SUMO-2和SUMO-3序列的检查表明,它们都含有序列psiKXE,这代表了SUMO修饰位点的共有序列。因此,SAE1/SAE2和Ubc9在体外催化蛋白质底物上SUMO-2和SUMO-3聚合链的形成,并且在体内检测到了SUMO-2链。SUMO-1不具备形成聚合链的能力,尽管所有SUMO种类都使用相同的缀合机制,但SUMO-1和SUMO-2/-3的修饰可能会产生不同的功能后果。